GRAIL Inc. (GRAL)
NASDAQ: GRAL
· Real-Time Price · USD
61.23
2.10 (3.55%)
At close: Oct 01, 2025, 1:52 PM
3.55% (1D)
| Bid | 61.01 |
| Market Cap | 2.21B |
| Revenue (ttm) | 134.28M |
| Net Income (ttm) | -442.95M |
| EPS (ttm) | -13.89 |
| PE Ratio (ttm) | -4.41 |
| Forward PE | -4.75 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 61.25 |
| Volume | 585,967 |
| Avg. Volume (20D) | 918,831 |
| Open | 58.79 |
| Previous Close | 59.13 |
| Day's Range | 58.50 - 62.69 |
| 52-Week Range | 12.33 - 63.99 |
| Beta | 3.20 |
| Ex-Dividend Date | n/a |
About GRAL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GRAL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GRAL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGRAIL Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+5.62%
GRAIL shares are trading higher after the company ...
Unlock content with
Pro Subscription
2 weeks ago
+9.12%
GRAIL shares are trading higher after the company reported better-than-expected Q2 EPS results.
2 months ago · seekingalpha.com
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic HeadwindsWith Illumina's divestiture of GRAIL, the company will improve its operating expenses, since GRAIL reported significant losses while it was part of Illumina. The global DNA sequencing market is expect...